$7.68 Billion is the total value of NEA Management Company, LLC's 63 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
COUR | Sell | COURSERA INC | $656,817,000 | -31.0% | 16,603,063 | -21.5% | 8.56% | -60.0% |
DM | Sell | DESKTOP METAL INC | $223,222,000 | -47.3% | 19,410,631 | -31.7% | 2.91% | -69.4% |
EAR | Sell | EARGO INC | $180,420,000 | -44.6% | 4,520,670 | -30.7% | 2.35% | -67.9% |
OPEN | Sell | OPENDOOR TECHNOLOGIES INC | $59,090,000 | -58.2% | 3,333,276 | -50.0% | 0.77% | -75.7% |
AFMD | Sell | AFFIMED NV | $37,625,000 | -12.0% | 4,426,488 | -18.1% | 0.49% | -49.0% |
UPST | Sell | UPSTART HLDGS INC | $35,858,000 | -51.5% | 287,092 | -49.9% | 0.47% | -71.8% |
DZSI | Exit | DZS INC | $0 | – | -38,470 | -100.0% | -0.01% | – |
MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -1,766,779 | -100.0% | -0.05% | – |
SPT | Exit | SPROUT SOCIAL INC | $0 | – | -1,545,040 | -100.0% | -2.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-02
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
TREVENA INC | 31 | Q3 2021 | 3.3% |
AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
ARDELYX INC | 29 | Q3 2021 | 11.9% |
RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.